Interleukin-2 in the development and control of inflammatory disease

被引:209
作者
Hoyer, Katrina K. [1 ]
Dooms, Hans [1 ]
Barron, Luke [1 ]
Abbas, Abul K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
关键词
interleukin-2; effector T cells; regulatory T cells;
D O I
10.1111/j.1600-065X.2008.00697.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-2 (IL-2) has multiple, sometimes opposing, functions during an inflammatory response. It is a potent inducer of T-cell proliferation and T-helper 1 (Th1) and Th2 effector T-cell differentiation and provides T cells with a long-lasting competitive advantage resulting in the optimal survival and function of memory cells. In a regulatory role, IL-2 is important for the development, survival, and function of regulatory T cells, it enhances Fas-mediated activation-induced cell death, and it inhibits the development of inflammatory Th17 cells. Thus, in its dual and contrasting functions, IL-2 contributes to both the induction and the termination of inflammatory immune responses.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 88 条
  • [1] IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
    Ahmadzadeh, M
    Rosenberg, ST
    [J]. BLOOD, 2006, 107 (06) : 2409 - 2414
  • [2] Lymphocyte survival - The struggle against death
    Arch, RH
    Thompson, CB
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 : 113 - 140
  • [3] TH-17 cells in the circle of immunity and autoimmunity
    Bettelli, Estelle
    Oukka, Mohamed
    Kuchroo, Vijay K.
    [J]. NATURE IMMUNOLOGY, 2007, 8 (04) : 345 - 350
  • [4] BONOMO A, 1995, J IMMUNOL, V154, P6602
  • [5] Interleukin-2-deficient mice develop colitis in the absence of CD28 costimulation
    Boone, DL
    Dassopoulos, T
    Lodolce, JP
    Chai, S
    Chien, M
    Ma, A
    [J]. INFLAMMATORY BOWEL DISEASES, 2002, 8 (01) : 35 - 42
  • [6] Selective stimulation of T cell subsets with antibody-cytokine immune complexes
    Boyman, O
    Kovar, M
    Rubinstein, MP
    Surh, CD
    Sprent, J
    [J]. SCIENCE, 2006, 311 (5769) : 1924 - 1927
  • [7] Association of the interleukin-2 receptor alpha (IL-2Rα)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs
    Brand, Oliver J.
    Lowe, Christopher E.
    Heward, Joanne M.
    Franklyn, Jayne A.
    Cooper, Jason D.
    Todd, John A.
    Gough, Stephen C. L.
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (04) : 508 - 512
  • [8] IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells
    Brandenburg, Susan
    Takahashi, Takeshi
    de la Rosa, Maurus
    Janke, Marko
    Karsten, Gabriele
    Muzzulini, Till
    Orinska, Zane
    Bulfone-Paus, Silvia
    Scheffold, Alexander
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (06) : 1643 - 1653
  • [9] BROOME HE, 1995, J IMMUNOL, V155, P2311
  • [10] IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells
    Burchill, Matthew A.
    Yang, Jianying
    Vogtenhuber, Christine
    Blazar, Bruce R.
    Farrar, Michael A.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (01) : 280 - 290